Exagen Inc. (NASDAQ: XGN) is a patient-focused and discovery-driven commercial-stage life sciences company, that aids patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. A relentless pursuit for laboratory excellence has enabled Exagen to develop next-generation autoimmune testing to help empower physicians and improve patients' lives.  

Learn more about Exagen Inc on their website https://exagen.com/ 

================================================================= 

TodaysStocks.com Today's News for Tomorrows Investor  

Find out more @ https://todaysstocks.com/   

Want to book a CEO Interview with Pat Bolland? Click here↓  

https://stockmkt.info/3wQaurn   

Want to book a News Release Interview with Natalie Stoberman? Click here↓ 

https://stockmkt.info/3wRITY5   

Follow us Facebook: https://www.facebook.com/TodaysStocksNow   

Follow us on Twitter: https://twitter.com/TodaysStocksNow 

________________________________________________________________   

TodaysStocks.com does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of TodaysStocks.com and do not constitute investment advice. All readers and viewers are encouraged to perform their own due diligence.